GTX Genetix Grp

RNS Number:8826Q
Genetix Group PLC
06 September 2005

6 September 2005



                               Genetix Group plc
                               Directorate Change


The Board of Genetix announces the resignation of Gary Corsi, Finance Director,
with effect from 31 January 2006. Gary is leaving the Group to take-up a new
position in a different sector.


The Board would like to thank Gary for his contribution over the five years that
he has been with Genetix and wishes him every success for the future.


During his notice period Gary will continue in the role of Finance Director. In
the meantime the Board has commenced a search for his successor.





Enquiries:



Genetix Group plc
Mark Reid, Chief Executive
Tel:  01425 624600



Financial Dynamics
Sarah MacLeod
Tel: 020 7831 3113





Notes to Editors

Genetix provides automated systems for cell biology, and proteomic and genomic
research. It supplies many leading academic institutions world-wide and major
international companies involved in the drug discovery process including GSK,
AstraZeneca and Novartis.



Genetix made a significant contribution to the Human Genome Project by supplying
high-throughput equipment to seven of the leading eight laboratories of the
consortium. Genetix, through its R&D expertise and scientific resource, is
committed to the continual development of innovative solutions to accelerate the
rate of global scientific discovery.



Genetix is quoted on the London Stock Exchange (symbol GTX) and is based in New
Milton, Hampshire, UK.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOABQLFBEKBEBBF

x

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Sep 2023 to Sep 2024